Officials urge those who left school without lifesaving vaccine to get protected
It comes amid warnings that more than 418,000 children have left school with no protection against human papillomavirus (HPV) in the last three years.
The HPV vaccine is offered to boys and girls when they are in Year 8 and is key to wiping out cervical cancer in the UK.
Around 13 high-risk types of HPV are known to cause 99.7% of cervical cancers.
The jab also protects against genital warts and head and neck cancers, such as those in the mouth or throat.
Now, GP practices in England will invite 16 to 25-year-olds to have the vaccine if records show they did not have it in school.
According to NHS England, more than 418,000 children left school without having the jab in the last three years, with concerns there are many more people aged 16 to 25 who are not protected.
Dr Amanda Doyle, national director of primary care and community services, said: 'This vaccine is hugely important in our fight to eradicate cervical cancer but it isn't just for girls and women – it's also vital for boys and men to get vaccinated to protect themselves against cancers of the mouth, throat or genitals, while preventing spreading the HPV infection to sexual partners who could then develop cervical cancer.
'Too many lives are lost to cervical cancer so the hard work of NHS staff across the country in vaccinating and screening as many people as possible will help us to meet our ambition of wiping out this disease.
'Encouraging progress has been made recently in increasing uptake but we know there is much more to do.
'So if you're eligible for a HPV vaccination or are the parent of a child who is eligible, but didn't get the vaccine at school when they had the chance, I would urge you to come forward when your GP contacts you.
'Only a single dose is required and it could save you or your child's life.'
Data shows that in the 2023/24 academic year, some 76.7% of girls and 71.2% of boys aged 14 to 15 were vaccinated against HPV by Year 10.
Uptake in Year 8 increased to 72.9% among girls and 67.7% among boys, from 71.3% and 65.2% respectively a year earlier.
The health service will aim to boost uptake among girls to 90% as part of plans to eliminate cervical cancer by 2040.
It will also aim to increase the number of women attending cervical cancer screening appointments.
Public health minister Ashley Dalton said the vaccine 'is our most powerful tool in our fight to eliminate cervical cancer by 2040' but said there is a 'long way to go'.
'Thousands of young people are still unvaccinated and vulnerable to this disease – which is so easily prevented,' she added.
Last month, the UK Health Security Agency (UKHSA) warned young women in some parts of England are at greater risk of cervical cancer because not enough children are getting the jab.
Analysis by the agency showed inequalities in vaccine uptake in some regions – by Year 10, HPV coverage in girls was lowest in London (64.9%) and highest in the South East (82.7%).
Among boys, it was also lowest in London (58.9%) and highest in the South East (77.3%).
Meanwhile, at local authority level, Year 10 vaccination levels in girls ranged from 38.7% (Lambeth in London) to 97.6% (Northumberland).
Among boys, it ranged from 28.2% (Lambeth in London) to 92.2% (West Berkshire).
Dr Sharif Ismail, consultant epidemiologist at UKHSA, said: 'We know that uptake of the HPV vaccination in young people has fallen significantly since the pandemic, leaving many, many thousands across the country at greater risk of HPV-related cancers.
'This is a real concern as each HPV vaccine, now just a single dose offered in schools, gives a young person good protection against the devastating impact of these cancers, which includes cervical, genital, mouth and throat cancers.
'This new catch-up campaign is a really important opportunity for us to make sure that no teenage girl or boy, young woman or man is denied that protection.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Imported dogs could carry disease or behaviour risk, RSPCA warns
An animal charity has called for stricter regulations on animal rescues importing dogs into the UK, citing concerns about disease risks and behavioural issues Government statistics reveal that in 2023, 320,000 pets were brought into the UK under travel pet schemes and 44,000 entered as commercial imports. RSPCA spokesman David Bowles likened the process to 'Deliveroo for dogs' and called on the Government to tighten regulations on animal rescues. He told the BBC: 'The RSPCA's major concern is these dogs are essentially ticking time bombs – coming over, not being health tested. 'Diseases are now coming in through these dogs. They're affecting not just the dogs that are being imported, they could also affect the dogs already in this country and their owners. 'They've almost set up a Deliveroo for dogs and that is a real problem.' There is no requirement for rescue organisations to be licensed in England, Wales or Northern Ireland. It comes weeks after a bill that aims to stop animal smuggling and cruelty cleared the Commons with cross-party support. Legislation put forward by Liberal Democrat MP Dr Danny Chambers will reduce the number of animals for non-commercial entry into the UK, ban the import of puppies and kittens under six months old or heavily pregnant dogs and cats, and introduce a halt on the import of dogs and cats who have been 'mutilated', including having their ears docked. The MP for Winchester's Animal Welfare (Import of Dogs, Cats and Ferrets) Bill was supported by the Government, and will now proceed to the House of Lords on its passage to becoming law. Dr Chambers said: 'As a vet, I've seen the devastating consequences of puppy smuggling. It's unimaginably cruel to separate puppies and kittens from their mothers at a very young age, and then bring them across borders in substandard conditions where they're then sold for maximum profit by unscrupulous traders who prioritise profit over welfare.' He added: 'Careful consideration has been given to setting these limits, balancing the need to disrupt illegal trade with minimising impact on genuine pet owners. To underpin this, only an owner, not an authorised person, will be permitted to sign and declare that the movement of a dog or cat is non-commercial. He criticised the influence of social media on the increased demand for dogs with docked ears, and a party colleague hit out at the platforms' role in publishing animal abuse. He said: 'One reason that there is such an interest in dogs with cropped ears is that a lot of influencers on Instagram and other social media platforms pose with these dogs or show they have these new dogs with cropped ears. Many people aren't aware that this is a mutilation. 'They think it's how the dogs' ears normally look, and it drives a demand for dogs that look like this.'
Yahoo
13 minutes ago
- Yahoo
Pharmacies warn of unsustainable demand for weight loss medication
The booming demand for weight loss jabs may be unsustainable, pharmacists warn. Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'
Yahoo
an hour ago
- Yahoo
Pharmacy warning of unsustainable demand for weight loss medication
The National Pharmacy Association (NPA) has issued a warning that the burgeoning demand for weight loss injections may be unsustainable, citing a significant mismatch between public interest and clinical suitability for the treatments. The NPA, which represents over 6,000 independent community pharmacies, highlighted this concern. A poll commissioned by the association revealed that 21 per cent of respondents had attempted to access weight loss treatments in the past year, either online or directly from a pharmacy. This figure surged to 35 per cent among 16 to 34-year-olds, contrasting sharply with just seven per cent of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'
